Session » RA – Etiology & Pathogenesis Poster

Date: Saturday, November 7, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 0786

A Combination of Dimensionality Reduction Techniques Reveals Novel HLA-DR+ ‘Candidate’ Antigen-Presenting Cell Subsets (cAPC) in Patients with Rheumatoid Arthritis (RA)

9:00AM-11:00AM: Abstract Number: 0767

Anti-acetylated Protein Antibodies in Rheumatoid Arthritis (RA): Clues for the Starting Point of Autoantibody Responses in RA

9:00AM-11:00AM: Abstract Number: 0779

Antibody Responses to Epstein-Barr Virus Are Altered in the Pre-Clinical Period of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0778

Bacterial Families Lachnospiraceae/Ruminococcaceae Are Immunologically Targeted in Individuals At-risk for RA and a Specific Strain Is Arthritogenic in Monocultured Gnotobiotic Mice

9:00AM-11:00AM: Abstract Number: 0777

CLEC12A Expression as a Potential Predictor of Disease Activity in Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0796

Development of a Tool to Assess Synovial Tissue Infiltrates and Derive Histological Pathotype in Inflammatory Arthritis: Relationship to Clinical and Ultrasound Variables

9:00AM-11:00AM: Abstract Number: 0769

Does the Autoantibody-Response Mature Between Presentation with Arthralgia and Development of Rheumatoid Arthritis? – a Longitudinal Serological Study

9:00AM-11:00AM: Abstract Number: 0768

Dynamics of Follicular Helper T Cells Subsets in Rheumatoid Arthritis Patients Before and After Treatment

9:00AM-11:00AM: Abstract Number: 0770

Effect of Citrullination on the Processing and Presentation of Rheumatoid Arthritis Autoantigens

9:00AM-11:00AM: Abstract Number: 0782

Epigenetic Regulation of Metabolic Transporters in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

9:00AM-11:00AM: Abstract Number: 0771

Factors Associated to Clinical and Radiographic Disease Progression in Patients with Early RA and First-degree Relatives: A 1-year Follow-up

9:00AM-11:00AM: Abstract Number: 0785

Identification of Recruited CCR2+ Inflammatory Monocytes in a Mouse Model of RA-associated Lung Disease with Potential Role for resolvin-D1 in Reducing Monocyte Inflammatory Responses

9:00AM-11:00AM: Abstract Number: 0792

LY294002 Improves the Collagen-induced Arthritis by Inducing Neutrophil Apoptosis

9:00AM-11:00AM: Abstract Number: 0789

Matrix Gla Protein (MGP) Modified with Malondialdehyde/Acetaldehyde Is Increased in Rheumatoid Arthritis and Cardiovascular Patients

9:00AM-11:00AM: Abstract Number: 0787

MerTK Synovial Expression Correlates with Disease Activity and Treatment Response in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 0795

Minimum Clinically Important Improvement in Patients with Rheumatoid Arthritis Associates with Gut Microbiome

9:00AM-11:00AM: Abstract Number: 0772

Modification of THP-1 Cells with Malondialdehyde-Acetaldehyde Increases Cellular Calcium Load Rendering Cells Susceptible to Citrullination of Self-Proteins

9:00AM-11:00AM: Abstract Number: 0774

Nr4a1-high Arthritogenic T Cells from SKG Mice Are Associated with Markers of Recent and Chronic Antigen-stimulation and an Altered T Cell Receptor Repertoire

9:00AM-11:00AM: Abstract Number: 0791

Peficitinib Inhibits Angiogenesis via Suppression of VEGF Production in Rheumatoid Arthritis Fibroblast-like Synoviocytes

9:00AM-11:00AM: Abstract Number: 0794

Peripheral Blood T and B Lymphocyte Subsets in Arthritis in the Elderly

9:00AM-11:00AM: Abstract Number: 0781

Phenotypic and Functional Characterisation of Synovial Fluid-derived Fibroblast-like Synoviocytes in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0788

Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery

9:00AM-11:00AM: Abstract Number: 0783

Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype

9:00AM-11:00AM: Abstract Number: 0780

Subsets of Synovial Fluid Derived Fibroblast-like Synoviocytes in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0775

T and B Cell Responses to Common Tenascin-C Peptides in RA

9:00AM-11:00AM: Abstract Number: 0773

The Anti-carbamylated Fibrinogen Response in Rheumatoid Arthritis Targets a Specific Epitope on the γ-chain and Is Associated with a More Active Disease

9:00AM-11:00AM: Abstract Number: 0776

The Influence of Adipokine Profile and Periodontal Infection in Early Stages of Rheumatoid Arthritis and First-degree Relatives

9:00AM-11:00AM: Abstract Number: 0793

Topological Laser Capture Microscopy (LCM)-RNAseq to Map the Rheumatoid Arthritis (RA) Synovial Transcriptome

9:00AM-11:00AM: Abstract Number: 0784

Upregulation of Tyro3TK on CD14+CD16- Monocytes Promotes Osteoclast Formation in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 0790

Vitamin D Polygenetic Risk Score and the Association with RA Autoantibodies Among First-Degree Relatives of RA Subjects

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].